Searchable abstracts of presentations at key conferences in endocrinology

ea0031p65 | Clinical practice/governance and case reports | SFEBES2013

Peri-operative α-blockade: efficacy of intravenous phenoxybenzamine vs oral phenoxybenzamine in patients with phaeochromocytoma and paraganglioma

Hussain Shazia , Gunganah Kirun , Ashby Michael , Carpenter Robert , Waterhouse Mona , Druce Maralyn , Drake William , Akker Scott

Introduction: Regimens for pre-operative α and β-blockade for patients with secretory phaeochromocytomas/paragangliomas vary widely between centres. The worldwide lack of availability of intravenous phenoxybenzamine (Goldshield) has removed a useful tool in the management of phaeochromocytoma crisis and has necessitated a change in our institution’s routine pre-operative strategy. We compare pre, peri and post-operative surrogate measures of blockade in a cohort...

ea0031p243 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Re-occurrence of pancreatic insulinoma: an usual cause of hypoglycaemia

Anwuzia-Iwegbu Charles , Mian Ali , Hussain Shazia , Panteliou Eleftheria , Chahal Harvey , Drake Wiliam

A 42-year-old woman presented to her GP with episodes of feeling ‘shaky’ exacerbated by physical exercise and prolonged fast. She was previously diagnosed with an insulinoma in 2006 (serum glucose 1.6 mmol/l, serum insulin 3.1 mIU/l and serum C-peptide <165 pmol/l). CT abdomen /transabdominal ultrasound revealed a 1 cm insulinoma in the uncinate process of the pancreas and the patient later underwent pancreatic enucleation in 2006. Post pancreatic enucleation, 72...

ea0028p27 | Clinical biochemistry | SFEBES2012

Using the hyperaldosteronism cohort to define normative catecholamine levels for adrenal venous sampling

Sze Wing-Chiu , Matson Matthew , Druce Maralyn , Akker Scott , Chew Shern , Grossman Ashley , Drake William

Objective: (1) To review normative data for catecholamines using our cohort of hyperaldosteronism patients undergoing adrenal vein sampling. This adds to the previously published data of normative values in a cohort of patients with cortisol-producing adenoma. (2) To demonstrate the usefulness of the noradrenaline to adrenaline ratio in the interpretation of adrenal venous sampling results.Design: 38 patients underwent successful, bilateral adrenal venou...

ea0028p77 | Clinical practice/governance and case reports | SFEBES2012

Haemofiltration as a treatment for severe, resistant hypercalcaemia

Pittaway James , Raja Omair , O'Toole Sam , Gunganah Kirun , Srirangalingam Umasuthan , Hanson Philippa , Drake William

Introduction: We describe two patients admitted to our institution with severe hypercalcaemia, resistant to conventional treatment, requiring haemofiltration. Patient 1 was admitted to hospital with profound hypercalcaemia (5.8 mmol/L) secondary to primary hyperparathyroidism (PTH >263 Pmol/L). The hypercalcaemia had been discovered on a surgical admission 3 months previously and was being managed with 0.9% normal saline and pamidronate infusions at an outside hospital. On...

ea0028p191 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Maternal Obesity in Human Pregnancy is Associated with Altered Placental Expression of Key Genes in Fetal Growth During the First Trimester, but not at Term

O'Reilly James , Drake Amanda , Jones Rebecca , Critchley Hilary , Riley Simon , Seckl Jonathan , Reynolds Rebecca

Background: Maternal obesity during pregnancy is associated with adverse effects on fetal growth and development. As the placenta is a key organ regulating fetal growth, we hypothesized that maternal obesity is associated with altered placental expression and DNA methylation of genes regulating fetal growth and glucocorticoid metabolism and aimed to investigate this in first trimester (F; <12 weeks gestation) and term (T;>37 weeks gestation) placental tissues.<p cl...

ea0028p247 | Pituitary | SFEBES2012

A case series of corticotroph macroadenomas and Cushing’s: clinical characteristics and management

O'Toole Sam , Metcalfe Karl , Plowman Piers , Evanson Jane , Carpenter Robert , Drake Will

Background: Pituitary macroadenomas are an uncommon cause of Cushing’s disease. They present with a higher cortisol burden, are more aggressive and harder to cure and manage than microadenomas.Aims: To review the demographics, clinical features, biochemistry, radiology and required treatment modalities of a single-centre case series of corticotroph macroadenomas.Methods: Retrospective analysis and review of the case records of...

ea0019p240 | Pituitary | SFEBES2009

Endocrine consequences of childhood traumatic brain injury

Khadr S , Crofton P , Wardhaugh B , Roach J , Jones P , Drake A , Minns R , Kelnar C

Objectives: To determine the prevalence/aetiology/clinical significance of pituitary dysfunction following moderate/severe childhood traumatic brain injury (TBI).Subjects: Twenty-six survivors of childhood TBI (20 males). Age at study: 5.4–18.9 year (median 13 year). Median time since TBI: 4.5y (2.3–6.7 year). King’s outcome scale for childhood head injury (KOSCHI) rating: 11 good recovery, 15 moderate disability, two severe disability.</p...

ea0017oc3 | Endocrinology 1 | BSPED2008

Pituitary function after childhood traumatic brain injury

Khadr S , Crofton P , Wardhaugh B , Roach J , Jones P , Drake A , Minns R , Kelnar C

Objectives: To determine the prevalence and clinical significance of pituitary dysfunction following moderate/severe childhood traumatic brain injury (TBI).Subjects and methods: We recruited 25 survivors of childhood TBI (19 males). Age at study was 5.4–18.9y (median 13.0y). Median time since TBI: 4.4y (2.3–6.7y). Subjects provided an early morning urine sample for osmolality and underwent basal hormone evaluation at 0800–1000h, followed b...

ea0015p64 | Clinical practice/governance and case reports | SFEBES2008

Tuberculous disease of the pituitary

Waterhouse M , Berney D , Moore-Gillon J , Sabin I , Drake W

We present the case of a 44-year-old woman from Afghanistan who had lived in the UK for 2 years. She was admitted to hospital with headache. She gave an 8 months history of generalised headache, secondary amenorrhoea and weight gain. There was no history of polyuria or polydypsia. Examination revealed a bitemporal hemianopia to red pin confrontation. Investigations confirmed that she was panhypopituitary. In addition, she was vitamin D deficient. Imaging of the pituitary gland...

ea0015p91 | Clinical practice/governance and case reports | SFEBES2008

Growth hormone replacement in patients with treated germ cell tumours: safety issues

Chung Teng-Teng LL , Kelly Phillip , Metcalfe Karl , Akker Scott , Drake William , Monson John

The potential for primary tumour relapse is an important consideration during GH replacement therapy (GHR). We report 3 cases of relapse of intra cranial germ cell tumour (GCT) during GHR.Patient 1: An 11 year-old female presenting with visual loss and short stature due to a suprasellar malignant teratoma. She was successfully treated with bleomycin, etoposide and cisplatinum (BEP) and intrathecal chemotherapy. She suffered a first relapse two years late...